279 related articles for article (PubMed ID: 20452814)
1. Bisphosphonate-related osteonecrosis of the jaws: how to manage cancer patients.
Madrid C; Bouferrache K; Abarca M; Jaques B; Broome M
Oral Oncol; 2010 Jun; 46(6):468-70. PubMed ID: 20452814
[TBL] [Abstract][Full Text] [Related]
2. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
Urade M; Tanaka N; Furusawa K; Shimada J; Shibata T; Kirita T; Yamamoto T; Ikebe T; Kitagawa Y; Fukuta J
J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
[TBL] [Abstract][Full Text] [Related]
3. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
4. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
Dodson TB
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
[TBL] [Abstract][Full Text] [Related]
5. [Encounter of cancer cells with bone. Present status and problems in occurrence of bisphosphonate-related osteonecrosis of the jaws].
Urade M
Clin Calcium; 2011 Mar; 21(3):420-7. PubMed ID: 21358064
[TBL] [Abstract][Full Text] [Related]
6. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
7. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
[TBL] [Abstract][Full Text] [Related]
8. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
Ferlito S; Liardo C; Puzzo S
Minerva Stomatol; 2010; 59(11-12):593-601. PubMed ID: 21217623
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.
Bagan J; Scully C; Sabater V; Jimenez Y
Oral Oncol; 2009 Jul; 45(7):551-4. PubMed ID: 19251474
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis.
Bedogni A; Saia G; Bettini G; Tronchet A; Totola A; Bedogni G; Ferronato G; Nocini PF; Blandamura S
Oral Oncol; 2011 May; 47(5):420-4. PubMed ID: 21439892
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis.
Manfredi M; Merigo E; Guidotti R; Meleti M; Vescovi P
Int J Oral Maxillofac Surg; 2011 Mar; 40(3):277-84. PubMed ID: 21163625
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
13. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
14. Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study.
Vescovi P; Campisi G; Fusco V; Mergoni G; Manfredi M; Merigo E; Solazzo L; Gabriele M; Gaeta GM; Favia G; Peluso F; Colella G
Oral Oncol; 2011 Mar; 47(3):191-4. PubMed ID: 21292541
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.
Allen MR; Burr DB
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):61-70. PubMed ID: 19371816
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study.
Otto S; Abu-Id MH; Fedele S; Warnke PH; Becker ST; Kolk A; Mücke T; Mast G; Köhnke R; Volkmer E; Haasters F; Lieger O; Iizuka T; Porter S; Campisi G; Colella G; Ploder O; Neff A; Wiltfang J; Ehrenfeld M; Kreusch T; Wolff KD; Stürzenbaum SR; Schieker M; Pautke C
J Craniomaxillofac Surg; 2011 Jun; 39(4):272-7. PubMed ID: 20580566
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.
Pautke C; Bauer F; Otto S; Tischer T; Steiner T; Weitz J; Kreutzer K; Hohlweg-Majert B; Wolff KD; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum SR; Kolk A
J Oral Maxillofac Surg; 2011 Jan; 69(1):84-91. PubMed ID: 20971542
[TBL] [Abstract][Full Text] [Related]
19. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review.
Hewitt C; Farah CS
J Oral Pathol Med; 2007 Jul; 36(6):319-28. PubMed ID: 17559492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
